Investment Case – “Clinical Trials – The Canadian Advantage” – 2018
The case for running clinical trials in Canada, advantages and information (English, pdf format) Author/Presenter: CCTCC
Investment Case – “Clinical Trials – The Canadian Advantage” – 2018 – French
The case for running clinical trials in Canada, advantages and information (French, ppt format) Author/Presenter: CCTCC https://www.cctcc.ca/wp-content/uploads/2018/08/CCTCC_InvestmentCase_Updated-June-2018_French.pptx
Investment Case – “Clinical Trials – The Canadian Advantage” – 2018 – French
The case for running clinical trials in Canada, advantages and information (French, pdf format) Author/Presenter: CCTCC
Investment Case – “Clinical Trials – The Canadian Advantage” – 2018
The case for running clinical trials in Canada, advantages and information (English, ppt format) Author/Presenter: CCTCC https://www.cctcc.ca/wp-content/uploads/2018/02/CCTCC_CT-Investment-Case_June-2017_Final1.pptx
2018 Strategic Planning Report: A pan-Canadian Clinical Trial Strategy
Report and Key Result areas from the Strategic Planning process initiated in 2017 and facilitated by Intersol. Author/Presenter: CCTCC/Intersol
Proposed Data Collection for mCTA metrics draft
Proposed metrics on the usage of the mCTA Author/Presenter: CCTCC https://www.cctcc.ca/wp-content/uploads/2018/08/Proposed-Data-collection-for-mCTA-metrics-draft.xlsx
The CCTCC 2014-2017 Report to Stakeholders
Author/Presenter: CCTCC
Determining Canada’s needs for a pan-Canadian Clinical Trials Organization
Report from the Strategic Planning Workshop, June 28, 2017, Toronto, ON Author/Presenter: CCTCC/Intersol
Advancing the mCTA through collaboration with the CLEAR initiative (TransCelerate-supported project)
Results of the 2016 mCTA Consultation and Open Houses for Sponsors and release of mCTA version 8.0 Author/Presenter: CCTCC
mCTA version 8 use letter final
Letter template for sites and sponsors to confirm their adoption of the mCTA Author/Presenter: CCTCC https://www.cctcc.ca/wp-content/uploads/2018/08/mCTA-version-8-use-letter-final-draft.docx
